Olmighty 40H Tablet is a combination antihypertensive medication containing Hydrochlorothiazide 12.5 mg and Olmesartan Medoxomil 40 mg. Hydrochlorothiazide is a thiazide diuretic that promotes the excretion of sodium and water by inhibiting sodium reabsorption in the distal tubules of the kidneys, thereby reducing blood volume and lowering blood pressure. Olmesartan Medoxomil is an angiotensin II receptor blocker (ARB) that selectively inhibits the binding of angiotensin II to the AT1 receptor, leading to vasodilation and decreased aldosterone secretion. The combined action of these two agents provides effective blood pressure control by targeting different mechanisms involved in hypertension pathophysiology. Olmighty 40H is indicated for the treatment of essential hypertension, particularly in patients who require more than one antihypertensive agent to achieve optimal blood pressure control. The combination therapy has been shown to reduce the risk of cardiovascular events associated with hypertension. It is important to monitor renal function, electrolyte levels, and blood pressure regularly during treatment. Olmighty 40H should be used under medical supervision, with caution advised in patients with renal impairment, electrolyte imbalances, or hypersensitivity to sulfonamides or ARBs.